In order to evaluate the impact of HIV infection on mycobacteria-specific responses, it was important to first define and compare the profile of mycobacteria-specific CD4+ T cells in response to distinct antigen formulations commonly used to assess TB immune responses, such direct comparisons not having been reported to date. This evidence concerns the gene CD4 and tuberculosis.